Skip to main content
Top
Published in: Clinical Rheumatology 9/2016

01-09-2016 | Original Article

IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response

Authors: Mei Zeng, Wantai Dang, Baofeng Chen, Yufeng Qing, Wenguang Xie, Mingcai Zhao, Jingguo Zhou

Published in: Clinical Rheumatology | Issue 9/2016

Login to get access

Abstract

Acute gouty arthritis (AGA) is an auto-inflammatory disease characterized by resolving spontaneously, which suggests that negative feedback loops control inflammatory and immunological responses to monosodium urate (MSU) crystals. By now, the molecular mechanism for spontaneous resolution of acute GA remains unclear; this study was undertaken to evaluate whether IL-37 is involved in spontaneous resolution of AGA. A total of 45 acute GA (AGA),29 non-acute GA (NAGA) male patients and 82 male health control (HC) were involved in this study, we measured IL-7 expression in the peripheral blood mononuclear cells (PBMCs), together with levels of IL-1β, IL-6, IL-10, TNF-α and TGF-β1 in the serum. Further, we either inhibited IL-37 expression in human PBMCs with siRNA or over-expressed the cytokine in human macrophages. Pro-inflammatory cytokine IL-1β, IL-6, and TNF-α expressions were significantly higher in the AGA group than in the NAGA or HC group (P < 0.05, respectively). However, anti-inflammatory IL-37, TGF-β1, and IL-10 were greater in the NAGA group than in the AGA and HC groups (P < 0.05, respectively). Expression of IL-37 in MSU crystal-treated macrophages inhibited the expression of pro-inflammatory cytokines, whereas the abundance of these cytokines increased with silencing of endogenous IL-37 in human blood cells. However, anti-inflammatory TGF-β1 and IL-10 expressions in these supernatants were unaffected by over-expression or knockdown of IL-37. Our study indicates that IL-37 is an important anti-inflammatory cytokine in AGA by suppressing the production of pro-inflammatory cytokines. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of GA.
Literature
3.
go back to reference Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864PubMed Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864PubMed
4.
go back to reference Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966CrossRefPubMed Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966CrossRefPubMed
5.
go back to reference Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192–197CrossRefPubMed Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192–197CrossRefPubMed
6.
go back to reference Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521CrossRefPubMed Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521CrossRefPubMed
7.
8.
go back to reference Cronstein BN, Terkeltaub R (2006) The inflammatory process of gout and its treatment. Arthritis Res Ther 8:S1–S3CrossRef Cronstein BN, Terkeltaub R (2006) The inflammatory process of gout and its treatment. Arthritis Res Ther 8:S1–S3CrossRef
9.
go back to reference Ortiz-Bravo E, Sieck MS, Schumacher HR Jr (1993) Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 36:1274–1285CrossRefPubMed Ortiz-Bravo E, Sieck MS, Schumacher HR Jr (1993) Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 36:1274–1285CrossRefPubMed
10.
go back to reference Lioté F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al (1996) Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 39:1192–1198CrossRefPubMed Lioté F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al (1996) Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 39:1192–1198CrossRefPubMed
11.
go back to reference Falasca GF, Ramachandrula A, Kelley KA, O’Connor CR, Reginato AJ (1993) Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36:105–116CrossRefPubMed Falasca GF, Ramachandrula A, Kelley KA, O’Connor CR, Reginato AJ (1993) Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36:105–116CrossRefPubMed
12.
go back to reference Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fi broblast mitogenesis by urate crystalinduced IL-1. J Immunol 138(10):3213–3218PubMed Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fi broblast mitogenesis by urate crystalinduced IL-1. J Immunol 138(10):3213–3218PubMed
13.
go back to reference Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592CrossRefPubMedPubMedCentral Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592CrossRefPubMedPubMedCentral
14.
go back to reference Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452CrossRefPubMed Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452CrossRefPubMed
15.
go back to reference Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T (1989) Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169:291–296CrossRefPubMed Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T (1989) Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169:291–296CrossRefPubMed
16.
go back to reference Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC et al (2011) Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 70:1655–1663CrossRefPubMed Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC et al (2011) Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 70:1655–1663CrossRefPubMed
17.
go back to reference Anna S, Francesca O, Roberta R, Frallonardo P, Dayer JM, Punzi L (2012) Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis 71:621–624CrossRef Anna S, Francesca O, Roberta R, Frallonardo P, Dayer JM, Punzi L (2012) Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis 71:621–624CrossRef
18.
go back to reference Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014–1022CrossRefPubMedPubMedCentral Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014–1022CrossRefPubMedPubMedCentral
20.
go back to reference Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D et al (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127–147PubMed Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D et al (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127–147PubMed
21.
go back to reference Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61–71CrossRefPubMed Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61–71CrossRefPubMed
22.
go back to reference Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477–5482CrossRefPubMed Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477–5482CrossRefPubMed
23.
go back to reference Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510CrossRefPubMedPubMedCentral Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510CrossRefPubMedPubMedCentral
24.
go back to reference McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB et al (2011) Interleukin 37 expression protects mice from colitis. PNAS 108(40):16711–16716CrossRefPubMedPubMedCentral McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB et al (2011) Interleukin 37 expression protects mice from colitis. PNAS 108(40):16711–16716CrossRefPubMedPubMedCentral
25.
go back to reference Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ et al (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711CrossRefPubMed Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ et al (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711CrossRefPubMed
26.
go back to reference Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Lannitti RG et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. Plos Pathog 10(11), e1004462CrossRefPubMedPubMedCentral Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Lannitti RG et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. Plos Pathog 10(11), e1004462CrossRefPubMedPubMedCentral
27.
go back to reference Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y et al (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69CrossRefPubMedPubMedCentral Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y et al (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69CrossRefPubMedPubMedCentral
28.
go back to reference Zhao PW, Jiang WG, Wang L (2014) Plasma levels of IL-37 and correlation with TNF-a, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9, e95346CrossRefPubMedPubMedCentral Zhao PW, Jiang WG, Wang L (2014) Plasma levels of IL-37 and correlation with TNF-a, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9, e95346CrossRefPubMedPubMedCentral
29.
go back to reference Scanu A, Oliviero F, Gruaz L, Sfriso P, Pozzuoli A, Frezzato F et al (2010) High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals. Arthritis Res Ther 12:R23CrossRefPubMedPubMedCentral Scanu A, Oliviero F, Gruaz L, Sfriso P, Pozzuoli A, Frezzato F et al (2010) High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals. Arthritis Res Ther 12:R23CrossRefPubMedPubMedCentral
30.
go back to reference Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241CrossRefPubMed Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241CrossRefPubMed
31.
go back to reference Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50:2273–2280CrossRefPubMed Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50:2273–2280CrossRefPubMed
Metadata
Title
IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response
Authors
Mei Zeng
Wantai Dang
Baofeng Chen
Yufeng Qing
Wenguang Xie
Mingcai Zhao
Jingguo Zhou
Publication date
01-09-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3109-5

Other articles of this Issue 9/2016

Clinical Rheumatology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine